{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:00:05Z","timestamp":1769083205500,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T00:00:00Z","timestamp":1432252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T00:00:00Z","timestamp":1432252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Colonic brain-derived neurotrophic factor (BDNF) plays an essential role in pathogenesis of abdominal pain in diarrhea-predominant irritable bowel syndrome (IBS-D), but regulation on its expression remains unclear. We investigated the role of fecal supernatants (FSN) from IBS-D patients on regulating BDNF expression in colonic epithelial cells of human and mice. Using human Caco-2 cells, we found that IBS-D FSN significantly increased BDNF mRNA and protein levels compared to control FSN, which were remarkably suppressed by the serine protease inhibitor. To further explore the potential mechanisms, we investigated the impact of protease-activated receptor-2 (PAR-2) on BDNF expression. We found a significant increase in PAR-2 expression in Caco-2 after IBS-D FSN stimulation. Knockdown of PAR-2 significantly inhibited IBS-D FSN-induced upregulation of BDNF. Moreover, we found that phosphorylation of p38 MAPK, not NF-\u03baB p65, contributed to PAR-2-mediated BDNF overexpression. To confirm these results, we intracolonically infused IBS-D or control FSN in mice and found that IBS-D FSN significantly elevated colonic BDNF and visceral hypersensitivity in mice, which were both suppressed by the inhibitor of serine protease or antagonist of PAR-2. Together, our data indicate that activation of PAR-2 signaling by IBS-D FSN promotes expression of colonic BDNF, thereby contributing to IBS-like visceral hypersensitivity.<\/jats:p>","DOI":"10.1038\/srep10121","type":"journal-article","created":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T12:17:23Z","timestamp":1432297043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Increased production of BDNF in colonic epithelial cells induced by fecal supernatants from diarrheic IBS patients"],"prefix":"10.1038","volume":"5","author":[{"given":"Peng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei-Xue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Li","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,22]]},"reference":[{"key":"BFsrep10121_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1053\/gast.2000.16484","volume":"119","author":"IM Gralnek","year":"2000","unstructured":"Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B. & Mayer, E. A. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119, 654\u201360 (2000).","journal-title":"Gastroenterology"},{"key":"BFsrep10121_CR2","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1053\/gast.2002.37095","volume":"123","author":"DA Drossman","year":"2002","unstructured":"Drossman, D. A., Camilleri, M., Mayer, E. A. & Whitehead, W. E. AGA technical review on irritable bowel syndrome. Gastroenterology 123, 2108\u201331 (2002).","journal-title":"Gastroenterology"},{"key":"BFsrep10121_CR3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/ajg.2011.86","volume":"106","author":"C Cremon","year":"2011","unstructured":"Cremon, C. et al. Intestinal serotonin release, sensory neuron activation and abdominal pain in irritable bowel syndrome. Am J. Gastroenterol 106, 1290\u20138 (2011).","journal-title":"Am J. Gastroenterol"},{"key":"BFsrep10121_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2006.11.039","volume":"132","author":"G Barbara","year":"2007","unstructured":"Barbara, G. et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132, 26\u201337 (2007).","journal-title":"Gastroenterology"},{"key":"BFsrep10121_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pneurobio.2008.04.004","volume":"85","author":"A Merighi","year":"2008","unstructured":"Merighi, A. et al. BDNF as a pain modulator. Prog. Neurobiol. 85, 297\u2013317 (2008).","journal-title":"Prog. Neurobiol."},{"key":"BFsrep10121_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/gutjnl-2011-300265","volume":"61","author":"YB Yu","year":"2012","unstructured":"Yu, Y. B. et al. Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome. Gut. 61, 685\u201394 (2012).","journal-title":"Gut."},{"key":"BFsrep10121_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/gut.2007.131839","volume":"57","author":"W Boesmans","year":"2008","unstructured":"Boesmans, W., Gomes, P., Janssens, J., Tack, J. & Vanden Berghe, P. Brain-derived neurotrophic factor amplifies neurotransmitter responses and promotes synaptic communication in the enteric nervous system. Gut. 57, 314\u201322 (2008).","journal-title":"Gut."},{"key":"BFsrep10121_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cgh.2006.12.004","volume":"5","author":"R Roka","year":"2007","unstructured":"Roka, R. et al. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 5, 550\u20135 (2007).","journal-title":"Clin Gastroenterol Hepatol."},{"key":"BFsrep10121_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.pain.2009.04.017","volume":"144","author":"A Annahazi","year":"2009","unstructured":"Annahazi, A. et al. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain. 144, 209\u201317 (2009).","journal-title":"Pain."},{"key":"BFsrep10121_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/gut.2007.140210","volume":"57","author":"K Gecse","year":"2008","unstructured":"Gecse, K. et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut. 57, 591\u20139 (2008).","journal-title":"Gut."},{"key":"BFsrep10121_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/gutjnl-2012-304042","volume":"63","author":"D Tooth","year":"2014","unstructured":"Tooth, D. et al. Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit. Gut. 63, 753\u201360 (2014).","journal-title":"Gut."},{"key":"BFsrep10121_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cyto.2005.06.004","volume":"31","author":"M Fyfe","year":"2005","unstructured":"Fyfe, M., Bergstrom, M., Aspengren, S. & Peterson, A. PAR-2 activation in intestinal epithelial cells potentiates interleukin-1beta-induced chemokine secretion via MAP kinase signaling pathways. Cytokine. 31, 358\u201367 (2005).","journal-title":"Cytokine."},{"key":"BFsrep10121_CR13","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.biocel.2007.10.031","volume":"40","author":"KW Lin","year":"2008","unstructured":"Lin, K. W., Park, J., Crews, A. L., Li, Y. & Adler, K. B. Protease-activated receptor-2 (PAR-2) is a weak enhancer of mucin secretion by human bronchial epithelial cells in vitro. Int. J. Biochem. Cell Biol. 40, 1379\u201388 (2008).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFsrep10121_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1254\/jphs.09155FP","volume":"111","author":"K Moriyuki","year":"2009","unstructured":"Moriyuki, K., Sekiguchi, F., Matsubara, K., Nishikawa, H. & Kawabata, A. Proteinase-activated receptor-2-triggered prostaglandin E(2) release, but not cyclooxygenase-2 upregulation, requires activation of the phosphatidylinositol 3-kinase\/Akt \/ nuclear factor-kappaB pathway in human alveolar epithelial cells. J. Pharmacol. Sci. 111, 269\u201375 (2009).","journal-title":"J. Pharmacol. Sci."},{"key":"BFsrep10121_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/nature04223","volume":"438","author":"JA Coull","year":"2005","unstructured":"Coull, J. A. et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438, 1017\u201321 (2005).","journal-title":"Nature"},{"key":"BFsrep10121_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2007.12.004","volume":"1206","author":"H Kobayashi","year":"2008","unstructured":"Kobayashi, H. et al. Expression changes of multiple brain-derived neurotrophic factor transcripts in selective spinal nerve ligation model and complete Freund\u2019s adjuvant model. Brain. Res. 1206, 13\u20139 (2008).","journal-title":"Brain. Res."},{"key":"BFsrep10121_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.neuropharm.2013.05.043","volume":"76","author":"E Edelmann","year":"2014","unstructured":"Edelmann, E., Lessmann, V. & Brigadski, T. Pre- and postsynaptic twists in BDNF secretion and action in synaptic plasticity. Neuropharmacology 76 Pt C, 610\u201327 (2014).","journal-title":"Neuropharmacology"},{"key":"BFsrep10121_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1053\/j.gastro.2005.12.026","volume":"130","author":"JR Grider","year":"2006","unstructured":"Grider, J. R., Piland, B. E., Gulick, M. A. & Qiao, L. Y. Brain-derived neurotrophic factor augments peristalsis by augmenting 5-HT and calcitonin gene-related peptide release. Gastroenterology 130, 771\u201380 (2006).","journal-title":"Gastroenterology"},{"key":"BFsrep10121_CR19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1042\/bj3141009","volume":"314","author":"SK Bohm","year":"1996","unstructured":"Bohm, S. K. et al. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem. J. 314 (Pt 3), 1009\u201316 (1996).","journal-title":"Biochem. J."},{"key":"BFsrep10121_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.coph.2004.08.004","volume":"4","author":"S Amadesi","year":"2004","unstructured":"Amadesi, S. & Bunnett, N. Protease-activated receptors: protease signaling in the gastrointestinal tract. Curr. Opin. Pharmacol. 4, 551\u20136 (2004).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFsrep10121_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1744-8069-10-28","volume":"10","author":"Y Bao","year":"2014","unstructured":"Bao, Y. et al. PAR2-mediated upregulation of BDNF contributes to central sensitization in bone cancer pain. Mol. Pain. 10, 28 (2014).","journal-title":"Mol. Pain."},{"key":"BFsrep10121_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neulet.2009.02.051","volume":"454","author":"MB Levanti","year":"2009","unstructured":"Levanti, M. B. et al. Enteric glial cells express full-length TrkB and depend on TrkB expression for normal development. Neurosci. Lett. 454, 16\u201321 (2009).","journal-title":"Neurosci. Lett."},{"key":"BFsrep10121_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrgastro.2013.29","volume":"10","author":"SJ Brookes","year":"2013","unstructured":"Brookes, S. J., Spencer, N. J., Costa, M. & Zagorodnyuk, V. P. Extrinsic primary afferent signalling in the gut. Nat. Rev. Gastroenterol Hepatol. 10, 286\u201396 (2013).","journal-title":"Nat. Rev. Gastroenterol Hepatol."},{"key":"BFsrep10121_CR24","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.neuroscience.2009.06.011","volume":"163","author":"R Katoh-Semba","year":"2009","unstructured":"Katoh-Semba, R. et al. Activation of p38 mitogen-activated protein kinase is required for in vivo brain-derived neurotrophic factor production in the rat hippocampus. Neuroscience 163, 352\u201361 (2009).","journal-title":"Neuroscience"},{"key":"BFsrep10121_CR25","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1523\/JNEUROSCI.5714-08.2009","volume":"29","author":"T Trang","year":"2009","unstructured":"Trang, T., Beggs, S., Wan, X. & Salter, M. W. P2\u2009\u00d7\u20094-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci. 29, 3518\u201328 (2009).","journal-title":"J. Neurosci."},{"key":"BFsrep10121_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1124\/jpet.111.187062","volume":"340","author":"RJ Lohman","year":"2012","unstructured":"Lohman, R. J. et al. Antagonism of protease-activated receptor 2 protects against experimental colitis. J. Pharmacol. Exp. Ther. 340, 256\u201365 (2012).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFsrep10121_CR27","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1111\/j.1476-5381.2011.01610.x","volume":"165","author":"JY Suen","year":"2012","unstructured":"Suen, J. Y. et al. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110). Br. J. Pharmacol. 165, 1413\u201323 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"BFsrep10121_CR28","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth, G. F. et al. Functional bowel disorders. Gastroenterology 130, 1480\u201391 (2006).","journal-title":"Gastroenterology"},{"key":"BFsrep10121_CR29","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/nprot.2007.392","volume":"2","author":"JA Christianson","year":"2007","unstructured":"Christianson, J. A. & Gebhart, G. F. Assessment of colon sensitivity by luminal distension in mice. Nat. Protoc. 2, 2624\u201331 (2007).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep10121","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep10121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep10121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T14:14:17Z","timestamp":1672928057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep10121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,22]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,9,22]]}},"alternative-id":["BFsrep10121"],"URL":"https:\/\/doi.org\/10.1038\/srep10121","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,22]]},"assertion":[{"value":"2 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10121"}}